Does recurrent aphthous stomatitis affect quality of life? A prospective study with 128 patients evaluating different treatment modalities

Basit Öğe Kaydı
dc.authorid0000-0003-2346-1865en_US
dc.authorid0000-0001-9226-5134
dc.contributor.authorHapa, Aslı
dc.contributor.authorAksoy, Berna
dc.contributor.authorPolat, Mualla
dc.contributor.authorAslan, Umut
dc.contributor.authorAtakan, Nilgün
dc.date.accessioned2021-06-23T19:27:53Z
dc.date.available2021-06-23T19:27:53Z
dc.date.issued2011
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractIntroduction: Quality of life measures are increasingly being used in the evaluation of oral disease outcome. To date, there has been less focus on oral health-related quality of life (OHR-QoL) measures for oral diseases in dermatologic literature. Objective: To test whether patients with recurrent aphthous stomatitis (RAS) report a lower OHR-QoL than the general population and to evaluate therapeutic regimens for RAS by using OHR-QoL measures. Method: A total of 128 patients and 40 controls were enrolled. A questionnaire entitled the 14-item oral health impact profile (OHIP-14) was completed. Forty-three (33%) of the patients were followed-up and completed the OHIP-14 following treatment. Results: The median total score of patients on colchicine before treatment was 21. Following use of colchicine, the total score was 10. There was a significant difference concerning the impact of oral health following use of oral colchicine. However, no reduction of OHIP-14 scores was observed in the topical treatment group. Conclusion: When the influence of one of the most common oral diseases such as RAS on OHR-QoL was taken into consideration, OHR-QoL provides an additional dimension that may help to improve the impact of a disease on an individual's life. In relation to this, colchicine seems to be one of the most effective management strategies used in RAS.en_US
dc.identifier.doi10.3109/09546631003675450
dc.identifier.endpage220en_US
dc.identifier.issn0954-6634
dc.identifier.issue4en_US
dc.identifier.pmid20804437en_US
dc.identifier.scopus2-s2.0-79960444553en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage215en_US
dc.identifier.urihttps://doi.org/10.3109/09546631003675450
dc.identifier.urihttps://hdl.handle.net/20.500.12491/6912
dc.identifier.volume22en_US
dc.identifier.wosWOS:000292780600007en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorPolat, Mualla
dc.language.isoenen_US
dc.publisherInforma Healthcareen_US
dc.relation.ispartofJournal Of Dermatological Treatmenten_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectOHIP-14en_US
dc.subjectOral Mucosal Diseasesen_US
dc.subjectQuality of Lifeen_US
dc.subjectRecurrent Aphthous Stomatitisen_US
dc.titleDoes recurrent aphthous stomatitis affect quality of life? A prospective study with 128 patients evaluating different treatment modalitiesen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
aslı-hapa.pdf
Boyut:
344.71 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Dahili Tıp Bilimleri Bölümü Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu